Patent ID: 8420644

Claim:
A method for treating cerebral edemas in an individual in need thereof, by inhibiting type A monoamine oxidase, comprising administering to said individual a therapeutically effective amount of at least one compound of formula (I) below: in which: n represents a whole number from 1 to 3, and the alkyl chain —(CH 2 ) n — can be linear or branched, X represents O or S; a represents a single or double bond and b represents 0 or 1, with the proviso that when b represents 0 then a represents a double bond and that when b represents 1 then a represents a single bond; c represents 0 or 1; NR 1 represents an NH group or a heterocycle with 5 or 6 atoms comprising 1 or 2 heteroatoms, the said heterocycle being possibly substituted by at least one hydroxyl or oxide group, with the proviso that when NR 1 represents NH then c represents 1 and that when NR 1 represents a heterocycle then c represents 0; R 2 , R 3 , R 4 , R 5 and R 6 , which may be identical or different, represent a group selected from the list comprising a hydrogen atom, a halogen atom, a hydroxyl group, a linear or branched alkyl group with 1 to 4 carbon atoms, a trifluoromethyl group or a nitro group; or of a pharmaceutically acceptable salt thereof; wherein said compounds are capable of inhibiting type A monoamine oxidase.